Dark Blue Therapeutics Ltd
- Company number
- 12645831
- Status
- Active
- Type
- Private Limited Company
- Incorporated
- 4 Jun 2020
- Nature of business
- Research and experimental development on biotechnology
- Corporate group
- Amgen UK Holdings Limited (3 companies)
Registered office
Officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| WALKER, Christopher Paul | Director | 30 Dec 2025 | 3 Jul 2026 |
Control
| Name | Nature of control | Notified | Ceased |
|---|---|---|---|
| Dr Andrew James Mclean | Ownership Of Shares 75 To 100 Percent Voting Rights 75 To 100 Percent Right To Appoint And Remove Directors |
4 Jun 2020 | 24 Jul 2020 |
| Oxford Science Enterprises Plc | Ownership Of Shares 25 To 50 Percent Voting Rights 25 To 50 Percent |
24 Jul 2020 | 17 Oct 2022 |
| Evotec International Gmbh | Ownership Of Shares 25 To 50 Percent Voting Rights 25 To 50 Percent |
21 Oct 2022 | 28 Jun 2024 |
| Oxford Science Enterprises Plc | Ownership Of Shares 25 To 50 Percent Voting Rights 25 To 50 Percent |
28 Jun 2024 | 30 Dec 2025 |
| Bms Strategic Portfolio Investments Holdings, Inc. | Ownership Of Shares 25 To 50 Percent Voting Rights 25 To 50 Percent |
17 Oct 2022 | 30 Dec 2025 |
| Amgen Uk Holdings Limited | Ownership Of Shares 75 To 100 Percent Voting Rights 75 To 100 Percent Right To Appoint And Remove Directors |
30 Dec 2025 |
Accounts
| Year ended |
|---|
| 30 Jun 2025 |
| 30 Jun 2024 |
| 30 Jun 2023 |
| 30 Jun 2022 |
| 30 Jun 2021 |
Connections
Owned by
Dark Blue Therapeutics Ltd → Amgen UK Holdings Limited
Controls
- Kleidox Therapeutics Ltd (12998606)
- Sandymount Therapeutics Ltd (13514842)